Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)

AIM: When selecting treatments for type 2 diabetes (T2D), it is important to consider not only efficacy and safety, but also other treatment attributes that have an impact on patient preference. The objective of this study was to examine preference between injection devices used for two weekly GLP‐1...

Descripción completa

Detalles Bibliográficos
Autores principales: Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Coyne, Karin S., Wullenweber, Paula K., Cutts, Katelyn N., Jordan, Jessica B., Wang, Qianqian, Yu, Maria, Currie, Brooke M., Malley, Karen G., Ishak, K. Jack, Hietpas, Ryan T., García‐Pérez, Luis‐Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064885/
https://www.ncbi.nlm.nih.gov/pubmed/31646727
http://dx.doi.org/10.1111/dom.13902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064885/
https://www.ncbi.nlm.nih.gov/pubmed/31646727
http://dx.doi.org/10.1111/dom.13902

Ejemplares similares